Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year
Castle Biosciences (Nasdaq: CSTL) announced it received the 2026 USA TODAY Top Workplaces USA Award on April 10, 2026, marking its fifth consecutive year on the list.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Castle Biosciences (Nasdaq: CSTL) announced it received the 2026 USA TODAY Top Workplaces USA Award on April 10, 2026, marking its fifth consecutive year on the list. The award recognizes organizations with 150+ employees based solely on confidential employee survey feedback.
The program is run by Energage and USA TODAY and measures workplace experience themes tied to high performance; the full 2026 Top Workplaces USA list is available on TopWorkplaces.com.
Details
News Market Reaction – CSTL
On Apr 10, the day this news came out, CSTL closed 1.28% below the previous close.
Data tracked by StockTitan Argus for the Apr 10 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
"Receiving a fifth straight Top Workplaces
Winners of the Top Workplaces
"Earning a
The comprehensive list of 2026 Top Workplaces
About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.
We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visit www.CastleBiosciences.com and connect with us on LinkedIn, Instagram, Facebook and X.
DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, AdvanceAD-Tx, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.
About Energage
Making the world a better place to work together.™
Energage is a purpose-driven company that helps organizations turn employee feedback into useful business intelligence and credible employer recognition through Top Workplaces. Built on 20 years of culture research and the results from 30 million employees surveyed across more than 80,000 organizations, Energage delivers the most accurate competitive benchmark available. With access to a unique combination of patented analytic tools and expert guidance, Energage customers lead the competition with an engaged workforce and an opportunity to gain recognition for their people-first approach to culture. For more information or to nominate your organization, visit energage.com or topworkplaces.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/castle-biosciences-earns-2026-usa-today-top-workplaces-award-for-fifth-consecutive-year-302738633.html
SOURCE Castle Biosciences, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.